GeoVax Capital Surpluse from 2010 to 2025

GOVXW Stock  USD 0.13  0  3.77%   
GeoVax Labs Capital Surpluse yearly trend continues to be fairly stable with very little volatility. Capital Surpluse will likely drop to about 44.5 M in 2025. During the period from 2010 to 2025, GeoVax Labs Capital Surpluse regression line of quarterly data had mean square error of 39.9 T and geometric mean of  41,814,837. View All Fundamentals
 
Capital Surpluse  
First Reported
2010-12-31
Previous Quarter
63.6 M
Current Value
44.5 M
Quarterly Volatility
10.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check GeoVax Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeoVax Labs' main balance sheet or income statement drivers, such as Depreciation And Amortization of 63.4 K, Interest Expense of 48.6 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 324, Dividend Yield of 0.0 or PTB Ratio of 2.61. GeoVax financial statements analysis is a perfect complement when working with GeoVax Labs Valuation or Volatility modules.
  
Check out the analysis of GeoVax Labs Correlation against competitors.
For more information on how to buy GeoVax Stock please use our How to Invest in GeoVax Labs guide.

Latest GeoVax Labs' Capital Surpluse Growth Pattern

Below is the plot of the Capital Surpluse of GeoVax Labs over the last few years. It is GeoVax Labs' Capital Surpluse historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GeoVax Labs' overall financial position and show how it may be relating to other accounts over time.
Capital Surpluse10 Years Trend
Slightly volatile
   Capital Surpluse   
       Timeline  

GeoVax Capital Surpluse Regression Statistics

Arithmetic Mean42,868,418
Geometric Mean41,814,837
Coefficient Of Variation24.01
Mean Deviation9,010,628
Median37,264,300
Standard Deviation10,293,524
Sample Variance106T
Range28.7M
R-Value0.81
Mean Square Error39.9T
R-Squared0.65
Significance0.0002
Slope1,741,268
Total Sum of Squares1589.3T

GeoVax Capital Surpluse History

202544.5 M
202463.6 M
202055.3 M
201939.3 M
201837.3 M
201735.6 M

About GeoVax Labs Financial Statements

GeoVax Labs investors use historical fundamental indicators, such as GeoVax Labs' Capital Surpluse, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in GeoVax Labs. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capital Surpluse63.6 M44.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for GeoVax Stock Analysis

When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.